Screenshot by Sean Hollister / The Verge
Elon Musk’s brain-computer interface company Neuralink says it has received Food and Drug Administration (FDA) approval to launch its first in-human clinical study. If this is true, it means that actual humans could be getting a device from Neuralink implanted in their heads.
The news follows Elon Musk’s November claim that Neuralink was about six months away from its first human trial — which suggests it’s the rare Musk promise that’s actually coming true on time. The announcement of a future human trial isn’t nearly as much of a milestone as the results of that trial. But this isn’t just any trial. This represents Elon Musk, of all people, getting to attach a device to a human brain.
We are excited to share that we have received the…
